728 x 90

As overdose deaths fall, White House makes misleading claims about who deserves credit

As overdose deaths fall, White House makes misleading claims about who deserves credit

Families look on as President Donald Trump speaks during a ceremony to sign the “Halt All Lethal Trafficking of Fentanyl Act” in the East Room of the White House on July 16, 2025. Evan Vucci/AP hide caption toggle caption i Evan Vucci/AP When the White House announced big improvements in the number of people dying

Families look on as President Donald Trump speaks during a ceremony to sign the "Halt All Lethal Trafficking of Fentanyl Act" in the East Room of the White House on July 16, 2025.

Families look on as President Donald Trump speaks during a ceremony to sign the “Halt All Lethal Trafficking of Fentanyl Act” in the East Room of the White House on July 16, 2025.

Evan Vucci/AP


hide caption

Evan Vucci/AP

When the White House announced big improvements in the number of people dying from fatal drug overdoses earlier this week, officials pointed to hopeful new data from the Centers for Disease Control and Prevention showing U.S. drug deaths have plunged to their lowest level in roughly a decade, saving nearly 50,000 lives each year.

But leading drug policy researchers say the White House statement also made misleading claims about the timing and cause of the remarkable public health success when it said that gains occurred primarily over the last 18 months due to policies enacted under President Trump’s leadership.

“The historic decline in drug overdose deaths demonstrates that America is unequivocally winning the fight against illicit drugs,” White House Office of National Drug Control Policy director Sara Carter said in a statement.

Carter credited heightened border security under Trump and claims of success dismantling “narco-terrorist” organizations for the recovery. “Critically, this represents a an approximately 41.5% decrease in total drug overdose deaths compared to the peak under the previous administration,” the statement said.

What the White House failed to disclose is that declines in overdose fatalities began much earlier, under the Biden administration, with most of the gains occurring before Trump returned to office.

“Since the spring of 2023, we have seen a steady decline in overdose deaths,” said Vanda Felbab-Brown, a drug policy expert at the Brookings Institution. “The fact that it has been sustained is very important.”

Fentanyl crisis on Biden’s watch, then a pivot toward fewer deaths

According to CDC data, reductions in drug deaths began in 2023 and have continued steadily for at least 39 consecutive months — not 18 months as the ONDCP statement said. By the time Biden left office, fatal overdoses had already dropped by roughly one-third, an improvement described by addiction experts at the time as unprecedented.

Nabarun Dasgupta, a street drug researcher at the University of North Carolina at Chapel Hill, was one of the first scientists to detect the stunning drop in overdose deaths. He said the trend toward fewer deaths began in some regions and among some demographic groups as early as 2021 and rapidly gained momentum nationwide.

“It was really the period early 2024 through spring 2025 where we were seeing the greatest rate of decline that we’ve ever seen,” Dasgupta said.

Deaths from fentanyl smuggled into the U.S. from Mexico first began to rise in 2013 during President Obama’s time in office and accelerated during Trump’s first term. Fentanyl overdoses spiked sharply the first two years of Biden’s presidency, during the COVID-19 pandemic. Despite progress, fentanyl remains the leading cause of drug deaths nationwide.

{For more tech updates, stay tuned to our blog.|Keep following us for the latest insights.|Check back often for more exciting news!}

Posts Carousel

Latest Posts

Top Authors

Most Commented

Featured Videos